[Articles] Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Bioportfolio,
ChAd3-EBO-Z was immunogenic and well tolerated in children aged 1–17 years. This study provides the first ChAd3-EBO-Z data in a…